Scientists Discover Way To Treat Lung Cancer and Its Deadly Side Effect Together

A new approach using lipid nanoparticles to deliver genetic material is showing promise in tackling two major challenges in ...

Not wanting to eat protein may be early herald of cancer cachexia

A majority of people with advanced cancers endure cachexia, a muscle-, fat-, and organ-wasting condition that is currently ...

Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic ...

Expanded case series includes advanced thymic carcinoma, small cell lung cancer, pancreatic cancer, end-stage liver cirrhosis, and end-stage ...

Exclusive: Penny stock Curanex expands cachexia focus backed by patient recovery narratives

Curanex Pharmaceuticals Inc. CURX on Wednesday highlighted five additional patient cases that management believes further ...

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution ...

Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Jericho, New York, April 02, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals, Inc. (Nasdaq: CURX) ...

Exclusive: Curanex highlights case study supporting cachexia focus in oncology strategy

Curanex Pharmaceuticals Inc. CURX on Monday said that a recent patient case study may reinforce its strategic push into ...
Medscape

Melatonin No Help for Cancer Cachexia

The dietary supplement melatonin does not improve the symptoms of cachexia in patients with advanced cancer, according to a study published online February 25 in the Journal of Clinical Oncology.
Business Wire

Cancer Cachexia Therapeutics Market 2019-2023 | High Prevalence and Incidence of Cancer Cachexia to Boost Growth | Technavio

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the cancer cachexia therapeutics market and it is poised to grow by USD 568.85 million during 2019-2023, progressing at a CAGR of 6% during the ...